Glaxosmithkline Pharmaceuticals Ltd.

Financial

	Glaxosmithkline Phar	Glenmark Pharma	Ipca Laboratories
Operational Metrics
Pharmaceutical Sector
Domestic Sales Growth - YoY	7.8 %	10.3 %	8.3 %
R&D as a % of Total Sales	0.07 %	7.3 %	3.12 %
Financials
5 yr Average ROE	40.73 %	4.18 %	13.55 %
5yr average Equity Multiplier	1.9	1.88	1.52
5yr Average Asset Turnover Ratio	0.94	0.79	0.76
5yr Avg Net Profit Margin	24.91 %	2.73 %	11.88 %
Price to Book	24.04	6.52	4.99
P/E	49.36	76.53	44.57
5yr Avg Cash Conversion Cycle	-107.65 Days	-121.67 Days	54.3 Days
Inventory Days	52.59 Days	40.44 Days	102.83 Days
Days Receivable	22.78 Days	36.38 Days	72.68 Days
Days Payable	144.46 Days	201.37 Days	111.38 Days
5yr Average Interest Coverage Ratio	479.64	3.48	50.79
5yr Avg ROCE	44.44 %	16.29 %	17.31 %
5yr Avg Operating Profit Margin	25.23 %	15.62 %	19.8 %
5 yr average Debt to Equity	0.0	0.49	0.17
5yr CAGR Net Profit	20.96 %	n/a	-8.34 %
5yr Average Return on Assets	21.84 %	1.86 %	9.41 %
Shareholdings
Promoter Holding	75.0 %	46.65 %	44.72 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	0.0	-1.57 %
Change in Mutual Fund Holding (3 Yrs)	1.11 %	9.74 %	0.2 %

Business

	Glaxosmithkline Phar	Glenmark Pharma	Ipca Laboratories
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 76.0 Vaccines 24.0 Glenmark Pharma (Branded generics) 0 Glenmark generics 0 API 0 Generics 0 Branded Generics 0	Product Wise Break-Up Branded Generics 0 API 0 Formulations 39.54 Vaccines 0 Branded Generics 60.46 Generics 0 Pharmaceutical 0	Product Wise Break-Up Branded Generics 50.39 Active Pharmaceutical Ingredient (API) 16.53 Glenmark generics 0 Vaccines 0 Glenmark Pharma (Branded generics) 0 Formulations 33.08 Pharmaceutical 0
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Dermatology 30.55 Anti-Infective 22.25 Vaccines 12.64 Pain Management 11.96 Hormones 8.91 Vitamins / Minerals / Nutrients 6.47 Respiratory 3.95 Pain 0 Neutraceuticals 0 Urology 0 Cough Preparations 0 Neuro Psychiatry 0 Gastro-Intestinal (GI) Products 0 Anti-Bacterials 0 Anti-Malarials 0 Cardiovasculars & Anti-Diabetics 0 0 Others 3.27	-	Therapeutic Area Wise Break-Up - Domestic Cough and colds 4.0 Pain 53.0 Respiratory 0 Anti-Infective 0 Anti Malarials 3.0 Hormones 0 Gastro Intestinal 2.0 0 Central Nervous System (CNS) 3.0 Anti-bacterial 5.0 Neutraceuticals 1.0 Vaccines 0 Vitamins / Minerals / Nutrients 0 Cardiac Science 17.0 Dermatology 6.0 Urology 5.0 Pain Management 0 Others 1.0
Location Wise Break-Up	Location Wise Break-Up India 98.65 Rest of the World 1.35 Europe 0 Latin America 0 North America 0 Asia (Excluding India) 0 Australia 0 CIS 0 USA 0 Africa 0	Location Wise Break-Up Africa 0 CIS 0 USA 0 North America 21.9 Australia 0 Europe 22.5 Latin America 0 India 29.0 Asia (Excluding India) 0 Rest of the World 24.3 Others 2.3	Location Wise Break-Up Africa 6.72 CIS 2.91 USA 21.58 North America 0 Australia 3.2 Europe 15.68 Latin America 0 India 44.73 Asia Pacific 5.18 Rest of the World 0
Acute vs Chronic	Acute vs Chronic Acute 99.0 Chronic 1.0	-	-

Glaxosmithkline Pharmaceuticals Ltd.

Glaxosmithkline Pharmaceuticals Ltd.

SIGN UP FOR FREE